Salivary Gland Cancer

Oncology
3
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
150%
Small Molecule
150%
+ 1 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AT
Actuate TherapeuticsFORT WORTH, TX
1 program
1
9-ING-41Phase 21 trial
Active Trials
NCT05010629Active Not RecruitingEst. Apr 2027
Genentech
GenentechCA - Oceanside
1 program
1
Ado-trastuzumabPhase 2Monoclonal Antibody1 trial
Active Trials
NCT04620187Recruiting55Est. Feb 2029
Ipsen
IpsenChina - Tianjin
1 program
1
CabozantinibPhase 2Small Molecule1 trial
Active Trials
NCT03729297Terminated25Est. Nov 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Actuate Therapeutics9-ING-41
GenentechAdo-trastuzumab
IpsenCabozantinib

Clinical Trials (3)

Total enrollment: 80 patients across 3 trials

NCT05010629Actuate Therapeutics9-ING-41

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Start: Sep 2021Est. completion: Apr 2027
Phase 2Active Not Recruiting
NCT04620187GenentechAdo-trastuzumab

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Start: Dec 2020Est. completion: Feb 202955 patients
Phase 2Recruiting
NCT03729297IpsenCabozantinib

Cabozantinib in Advanced Salivary Gland Cancer Patients

Start: Sep 2018Est. completion: Nov 201925 patients
Phase 2Terminated

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
2h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
2h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
2h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 80 patients
3 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)